chrX-101349551-A-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000061.3(BTK):​c.*334T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0139 in 229,791 control chromosomes in the GnomAD database, including 113 homozygotes. There are 668 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 100 hom., 605 hem., cov: 22)
Exomes 𝑓: 0.0039 ( 13 hom. 63 hem. )

Consequence

BTK
NM_000061.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.347

Publications

1 publications found
Variant links:
Genes affected
BTK (HGNC:1133): (Bruton tyrosine kinase) The protein encoded by this gene plays a crucial role in B-cell development. Mutations in this gene cause X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]
BTK Gene-Disease associations (from GenCC):
  • Bruton-type agammaglobulinemia
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Myriad Women’s Health, Orphanet, ClinGen
  • isolated growth hormone deficiency type III
    Inheritance: XL Classification: STRONG, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant X-101349551-A-C is Benign according to our data. Variant chrX-101349551-A-C is described in ClinVar as [Benign]. Clinvar id is 367692.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0842 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BTKNM_000061.3 linkc.*334T>G 3_prime_UTR_variant Exon 19 of 19 ENST00000308731.8 NP_000052.1 Q06187-1Q5JY90
BTKNM_001287344.2 linkc.*334T>G 3_prime_UTR_variant Exon 19 of 19 NP_001274273.1 Q06187-2
BTKNM_001287345.2 linkc.*334T>G 3_prime_UTR_variant Exon 17 of 17 NP_001274274.1 Q06187Q5JY90

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BTKENST00000308731.8 linkc.*334T>G 3_prime_UTR_variant Exon 19 of 19 1 NM_000061.3 ENSP00000308176.8 Q06187-1

Frequencies

GnomAD3 genomes
AF:
0.0251
AC:
2717
AN:
108243
Hom.:
99
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0869
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0106
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00117
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0338
Gnomad NFE
AF:
0.000346
Gnomad OTH
AF:
0.0111
GnomAD4 exome
AF:
0.00385
AC:
468
AN:
121500
Hom.:
13
Cov.:
0
AF XY:
0.00213
AC XY:
63
AN XY:
29584
show subpopulations
African (AFR)
AF:
0.0677
AC:
335
AN:
4946
American (AMR)
AF:
0.00664
AC:
35
AN:
5273
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
4971
East Asian (EAS)
AF:
0.00
AC:
0
AN:
12155
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3672
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
4098
Middle Eastern (MID)
AF:
0.00721
AC:
4
AN:
555
European-Non Finnish (NFE)
AF:
0.000220
AC:
17
AN:
77101
Other (OTH)
AF:
0.00882
AC:
77
AN:
8729
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.402
Heterozygous variant carriers
0
15
30
45
60
75
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0252
AC:
2724
AN:
108291
Hom.:
100
Cov.:
22
AF XY:
0.0194
AC XY:
605
AN XY:
31231
show subpopulations
African (AFR)
AF:
0.0870
AC:
2572
AN:
29574
American (AMR)
AF:
0.0106
AC:
107
AN:
10075
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2609
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3502
South Asian (SAS)
AF:
0.00117
AC:
3
AN:
2554
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5602
Middle Eastern (MID)
AF:
0.0370
AC:
8
AN:
216
European-Non Finnish (NFE)
AF:
0.000346
AC:
18
AN:
52037
Other (OTH)
AF:
0.0110
AC:
16
AN:
1460
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
85
171
256
342
427
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0227
Hom.:
75
Bravo
AF:
0.0316

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

X-linked agammaglobulinemia with growth hormone deficiency Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

X-linked agammaglobulinemia Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
3.4
DANN
Benign
0.56
PhyloP100
0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs183674618; hg19: chrX-100604539; API